Camtek (CAMT)
Builds inspection and metrology systems for semiconductor manufacturing and packaging.
Something off on this page? Send us feedback.
Sells inspection and metrology equipment spanning semiconductor fabrication and packaging. The former PCB business was sold, leaving a semiconductor-focused operation whose FRT Metrology acquisition extended high-precision capabilities into advanced packaging and silicon-carbide markets.
Develops and manufactures inspection and metrology equipment for semiconductor fabrication. Its systems span front- and mid-end production through post-dicing, serving manufacturers and packaging operations at multiple critical process points.
Became a semiconductor inspection supplier through its acquisition of MEP and a pure-play semiconductor company after selling its PCB inspection and metrology unit.
Added FRT Metrology, bringing high-precision capabilities for advanced packaging and silicon-carbide applications. Based in Migdal Ha'Emek, Israel, it remains led by founder Rafi Amit. The acquired business broadened its tools across a wider range of semiconductor manufacturing process steps.
Company facts
Target rangeAs of Sep 22, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Sep 22, 2026 | Cantor Fitzgerald | Reiterate | Rating: —Target: $120 | Target: $175 |
| Aug 11, 2026 | Morgan Stanley | Reiterate | Rating: —Target: $163 | Target: $165 |
| Aug 10, 2026 | Stifel Nicolaus | Target | Target: $185 | Target: $170 |
| May 13, 2026 | Evercore ISI | Target | Target: $190 | Target: $200 |
| May 13, 2026 | Northland Securities | Target | Target: $150 | Target: $174 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $630.4M · Total debt $488.5M · Total assets $1.34B · Shareholders' equity $710.2M
- Revenue
- $133.2M
- Operating income
- $27.2M
- Net income
- $23.3M
HistoryDividendAnnual yield
| Institutions | ≈ 43.09% | 19.75M ADS | |
|---|---|---|---|
| 256 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 0.26% | 119.6K ADS | |
| 9 holders · as of Aug 18, 2026 | |||
| Strategic holders | 22.27% | 10.20M ADS | |
| 2 holders · as of Aug 11, 2026 | |||
| Other | ≈ 34.38% | 15.76M ADS | |
| remainder | |||
45.83M ADS as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Chroma ATE Inc.Strategic | 17.06% | 7.82M | filed Aug 6, 2019 |
Migdal Insurance & Financial Holdings Ltd.Institution | 5.78% | 2.65M ADS | as of Jun 30, 2026 |
Phoenix Financial Ltd.Strategic | 5.21% | 2.39M | filed Aug 11, 2026 |
Harel Insurance Investments & Financial Services Ltd.Institution | 4.86% | 2.23M ADS | as of Jun 30, 2026 |
Wasatch Advisors LPInstitution | 4.63% | 2.12M ADS | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 17, 2026 | Orit Geva-Dvash | officer: Vice President, HR | −508 | $175.00 |
| Aug 14, 2026 | Karni Yarl Andorn | director | −3,176 | $164.40 |
| Aug 13, 2026 | Karni Yarl Andorn | director | −2,356 | $172.35 |
| Aug 13, 2026 | Rafi Amit | officer: Chief Executive Officer | −6,250 | $170.52 |
| Aug 13, 2026 | Ram Langer | officer: Chief Operating Officer | −6,387 | $172.32 |
- Onto Innovation
Direct rival in advanced-packaging inspection and optical metrology
- KLA
Broad process-control supplier in semiconductor packaging inspection
- Nova
Metrology and process-control supplier expanding in advanced packaging
- Bruker
3D optical-metrology supplier for advanced semiconductor packaging
CompareAfter hours
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Camtek | $151.36 | −0.11% | $6.98B | 245.3 | 33.3 | 13.7 | +8.1% |
| Onto Innovation | $283.81 | −0.04% | $13.73B | 103.8 | 27.7 | 12.3 | +35.3% |
| KLA | $187.78 | −0.29% | $240.32B | 50.2 | 34.1 | 17.7 | +15.2% |
| Nova | $369.95 | −0.08% | $11.53B | 45.1 | 29.8 | 12.3 | +15.9% |
| Bruker | $61.21 | −0.02% | $9.37B | — | 27.0 | 2.7 | +5.2% |
| Median | 50.2 | 28.7 | 12.3 | +15.6% |